Nomogram Predicting Lymph Node Metastasis in the Early-Stage Cervical Cancer
- PMID: 35847788
- PMCID: PMC9280490
- DOI: 10.3389/fmed.2022.866283
Nomogram Predicting Lymph Node Metastasis in the Early-Stage Cervical Cancer
Abstract
Background: Accurately predicting the risk level of lymph node metastasis is essential for the treatment of patients with early cervical cancer. The purpose of this study is to construct a new nomogram based on 2-deoxy-2-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) and clinical characteristics to assess early-stage cervical cancer patients' risk of lymph node metastasis.
Materials and methods: From January 2019 to November 2020, the records of 234 patients with stage IA-IIA [International Federation of Gynecology and Obstetrics (FIGO) 2018] cervical cancer who had undergone PET/CT examination within 30 days before surgery were retrospectively reviewed. A nomogram to predict the risk of lymph node metastasis was constructed based on it. The nomogram was developed and validated by internal and external validation. The validation cohorts included 191 cervical cancer patients from December 2020 to October 2021.
Results: Four factors [squamous cell carcinoma associated antigen (SCCA), maximum standardized uptake value of lymph node (nSUVmax), uterine corpus invasion in PET/CT and tumor size in PET/CT] were finally determined as the predictors of the nomogram. At the area under the receiver operating characteristic curve cohort was 0.926 in the primary and was 0.897 in the validation cohort. The calibration curve shows good agreement between the predicted probability and the actual probability. The decision curve analysis showed the clinical utility of the nomogram.
Conclusion: We had established and verified a simple and effective nomogram, which can be used to predict the lymph node metastasis of cervical cancer patients before surgery.
Keywords: PET/CT; cervical cancer; decision curve analysis; lymph node metastasis; nomogram.
Copyright © 2022 Yang, Liu, Li and Hua.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
![FIGURE 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9280490/bin/fmed-09-866283-g001.gif)
![FIGURE 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9280490/bin/fmed-09-866283-g002.gif)
![FIGURE 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9280490/bin/fmed-09-866283-g003.gif)
Similar articles
-
A novel 2-deoxy-2-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT)-based nomogram to predict lymph node metastasis in early stage uterine cervical squamous cell cancer.Quant Imaging Med Surg. 2021 Jan;11(1):240-248. doi: 10.21037/qims-20-348. Quant Imaging Med Surg. 2021. PMID: 33392025 Free PMC article.
-
A nomogram for predicting the risk of lymph node metastasis in T1-2 non-small-cell lung cancer based on PET/CT and clinical characteristics.Transl Lung Cancer Res. 2021 Jan;10(1):430-438. doi: 10.21037/tlcr-20-1026. Transl Lung Cancer Res. 2021. PMID: 33569324 Free PMC article.
-
Value of [18F]FDG PET radiomic features and VEGF expression in predicting pelvic lymphatic metastasis and their potential relationship in early-stage cervical squamous cell carcinoma.Eur J Radiol. 2018 Sep;106:160-166. doi: 10.1016/j.ejrad.2018.07.024. Epub 2018 Jul 27. Eur J Radiol. 2018. PMID: 30150039
-
Opportunities for 2-[(18)F] fluoro-2-deoxy-D-glucose PET/CT in cervical-vaginal neuroendocrine carcinoma: case series and literature review.Korean J Radiol. 2012 Nov-Dec;13(6):760-70. doi: 10.3348/kjr.2012.13.6.760. Epub 2012 Oct 12. Korean J Radiol. 2012. PMID: 23118575 Free PMC article. Review.
-
Value of non-coding RNAs to assess lymph node status in cervical cancer.Front Oncol. 2023 May 10;13:1144672. doi: 10.3389/fonc.2023.1144672. eCollection 2023. Front Oncol. 2023. PMID: 37234986 Free PMC article. Review.
Cited by
-
Validation of the 2018 FIGO staging system for stage IIIC cervical cancer by determining the metabolic and radiomic heterogeneity of primary tumors based on 18F-FDG PET/CT.Abdom Radiol (NY). 2024 Jun;49(6):2027-2039. doi: 10.1007/s00261-024-04226-7. Epub 2024 Mar 25. Abdom Radiol (NY). 2024. PMID: 38526594
-
Predictive value and potential association of PET/CT radiomics on lymph node metastasis of cervical cancer.Ann Med Surg (Lond). 2023 Nov 7;86(2):805-810. doi: 10.1097/MS9.0000000000001412. eCollection 2024 Feb. Ann Med Surg (Lond). 2023. PMID: 38333288 Free PMC article.
-
A preoperative prediction of lymph node metastasis in early cervical squamous cell cancer with hematologica - based model.J Cancer. 2023 Jun 19;14(10):1763-1772. doi: 10.7150/jca.85301. eCollection 2023. J Cancer. 2023. PMID: 37476184 Free PMC article.
-
Identifying the risk factors and developing a predictive model for postoperative pelvic floor dysfunction in cervical cancer patients.Transl Cancer Res. 2023 May 31;12(5):1307-1314. doi: 10.21037/tcr-23-385. Epub 2023 Apr 24. Transl Cancer Res. 2023. PMID: 37304532 Free PMC article.
-
Kimura disease, a rare cause of inguinal lymphadenopathy: A case report.Front Med (Lausanne). 2022 Sep 23;9:1023804. doi: 10.3389/fmed.2022.1023804. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36213635 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials